PHARMA AND BIOTECHNOLOGY ACTIVITIES IN INDIA
The Indian biotech industry has been booming over the past decade, growing from 23.5 Billion INR (Indian Rupee) (about 0.5 Billion US$) in 2002-03 to 172.5 Billion INR (more than 3.75 Billion US$) in 2010-11 (Figure 1, source: ‘Biospectrum/ABLE Biotech Industry Survey’, June 2011).
FIGURE 1: Indian biotech market (in Million US$)
The Indian biotech sector is estimated to count more than seven hundred players, but this includes the pharmaceutical sector with generics (small molecules, hormones, vaccines monoclonal antibodies), the bioagri industry (genetically modified crops, animal health), bioindustrial applications (bioenzymes, development of biofuels), the bioinformatics area (data warehousing, data mining, DNA sequencing, data management), equipment providers, and a wide range of bioservices.
The need for a better understanding of the potential of Indian biotech companies as actors or contributors to drug discovery and early development has been the trigger of our survey, which includes data on more than two hundred and forty companies, and is based on information available on company websites and in press releases. Our survey includes all activities and service offerings with a clear pharmaceutical drug discovery focus, ranging from biology, through to medicinal chemistry, pharmacology and integrated drug discovery, and up to preclinical development. It does not differentiate between service providers and companies whose business model is built on developing own IP and partnerships, as it can be considered that all these different activities can be available to potential clients or partners (Western pharma and biotech companies, research institutes or nonprofit organizations), be it through fee-for service/full-time-equivalent (FFS/FTE) models or through partnerships and licensing agreements.
January 3, 2012
25.02.13 | INNOVATIVE DRUG DISCOVERY IN INDIA – THE GROWING INDIAN R&D PIPELINE
Ranbaxy’s recently launched Synriam, together with Glenmark’s (and US partner Salix Pharmaceuticals’) approval of Crofelemer are only the two first visible signs of India’s growing presence in innovative drug discovery and development...
30.07.12 | BIOTECHNOLOGY IN INDIA – 2012 “BIOSPECTRUM-ABLE” SURVEY
According to the tenth annual Indian Biotech Industry survey by Biospectrum-ABLE (Association of Biotechnology Led Enterprises), the Indian biotech industry passed the 4 Billion US$ mark in 2011-12...
03.01.12 | INDIAN DRUG DISCOVERY PIPELINE
In the late nineteen eighties, Indian pharma companies started in-house drug discovery activities, aiming at developing the country’s first home-made drug ...
03.01.12 | PHARMA AND BIOTECHNOLOGY ACTIVITIES IN INDIA
The Indian biotech industry has been booming over the past decade, growing from 0.5 Billion US$ in 2002-03 to more than 3.75 Billion US$ in 2010-11, and counting more than seven hundred players. ...